Page last updated: 2024-08-24

4-pentenoic acid and Fatty Liver with Encephalopathy

4-pentenoic acid has been researched along with Fatty Liver with Encephalopathy in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19904 (40.00)18.7374
1990's3 (30.00)18.2507
2000's1 (10.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antelava, N; Ghonghadze, M; Liluashvili, K; Okujava, M; Pachkoria, K1
Abdin, A; Sarhan, N1
Thayer, WS1
Arbuzov, AG; Burkova, VN; Cherviakova, MB; Chuchalin, VS; Saratikov, AS; Sukhodolo, IV; VengerovskiÄ­, AI1
Applebaum, M; Masion Hoogenraad, NJ; Sinatra, F; Sunshine, P; Yoshida, T1
Yoshida, I1
Hidaka, T; Inokuchi, T; Kotegawa, M; Nakamura, Y; Ogura, R; Sugiyama, M1
Araki, A; Kobayashi, Y; Murakami, K; Nishida, N; Sugimoto, T; Woo, M1
Morii, S; Sakaida, N; Senzaki, H; Shikata, N1
Caspers, ML; Hart, MA; Swisher, JA1

Other Studies

10 other study(ies) available for 4-pentenoic acid and Fatty Liver with Encephalopathy

ArticleYear
[ACTION OF L-CARNITINE, CORVITIN AND THEIR COMBINATION ON FUNCTIONAL STATE OF LIVER IN EXPERIMENTAL MODEL OF REYE SYNDROME IN RATS].
    Georgian medical news, 2017, Issue:263

    Topics: Acetylcysteine; Animals; Chemical and Drug Induced Liver Injury; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Flavonoids; Liver; Male; Protective Agents; Random Allocation; Rats, Wistar; Reye Syndrome

2017
Resveratrol protects against experimental induced Reye's syndrome by prohibition of oxidative stress and restoration of complex I activity.
    Canadian journal of physiology and pharmacology, 2014, Volume: 92, Issue:9

    Topics: Ammonia; Animals; Antioxidants; Electron Transport Complex I; Fatty Acids, Monounsaturated; Malondialdehyde; Membrane Transport Proteins; Oxidative Stress; Prothrombin; Rats, Wistar; Resveratrol; Reye Syndrome; Serum Albumin; Serum Albumin, Human; Stilbenes; Transaminases

2014
Inhibition of mitochondrial fatty acid oxidation in pentenoic acid-induced fatty liver. A possible model for Reye's syndrome.
    Biochemical pharmacology, 1984, Apr-15, Volume: 33, Issue:8

    Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Acids; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Fatty Liver; Male; Mitochondria, Liver; Oxidation-Reduction; Rats; Rats, Inbred Strains; Reye Syndrome; Starvation

1984
[Effects of phospholipid hepatoprotective agents in experimental Reye syndrome].
    Biulleten' eksperimental'noi biologii i meditsiny, 2000, Volume: 129, Issue:3

    Topics: Animals; Antioxidants; Carotenoids; Drug Combinations; Fatty Acids, Monounsaturated; Liver; Male; Phosphatidylcholines; Phospholipids; Rats; Reye Syndrome

2000
Abnormalities of carbamyl phosphate synthetase and ornithine transcarbamylase in liver of patients with Reye's syndrome.
    Pediatric research, 1975, Volume: 9, Issue:11

    Topics: Animals; Brain Diseases; Carbamoyl-Phosphate Synthase (Ammonia); Child; Child, Preschool; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Female; Humans; Infant; Kinetics; Liver; Male; Mitochondria, Liver; Ornithine Carbamoyltransferase; Phosphotransferases; Rats; Reye Syndrome; Urea; Valerates

1975
Electronmicroscopic and energic aspects in 4-pentenoic acid induced-fatty liver model of Reyes syndrome.
    The Kurume medical journal, 1979, Volume: 26, Issue:3

    Topics: Adenosine Triphosphate; Animals; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Lipids; Liver; Male; Mitochondria, Liver; Rats; Reye Syndrome

1979
Prevention of 4-pentenoic acid-induced liver injury in rats by 16,16-dimethyl PGE2.
    Experimental and molecular pathology, 1991, Volume: 55, Issue:2

    Topics: 16,16-Dimethylprostaglandin E2; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Fatty Acids, Monounsaturated; Injections, Intraperitoneal; Lipid Metabolism; Lipids; Liver; Liver Diseases; Liver Glycogen; Male; Microscopy, Electron; Rats; Rats, Inbred Strains; Reye Syndrome

1991
The effect of L-carnitine supplementation in 4 pentenoic acid treated rats.
    Brain & development, 1990, Volume: 12, Issue:4

    Topics: Ammonia; Animals; Blood Glucose; Carnitine; Disease Models, Animal; Fatty Acids, Monounsaturated; Fatty Acids, Nonesterified; Fatty Liver; Liver; Male; Mitochondria, Liver; Muscles; Rats; Rats, Inbred Strains; Reye Syndrome

1990
Microvesicular fatty liver in rats with resembling Reye's syndrome induced by 4-pentenoic acid.
    Acta pathologica japonica, 1990, Volume: 40, Issue:9

    Topics: Animals; Diagnosis, Differential; Fatty Acids, Monounsaturated; Fatty Liver; Histocytochemistry; Hypoglycemia; Intracellular Membranes; Male; Microscopy, Electron; Mitochondria; Rats; Rats, Inbred Strains; Reye Syndrome; Triglycerides

1990
Alterations in plasma amino acids and hepatic enzymes in the 4-pentenoic acid model of Reye's syndrome.
    Biochemical pharmacology, 1989, May-15, Volume: 38, Issue:10

    Topics: Amino Acids; Ammonia; Animals; Disease Models, Animal; Fatty Acids, Monounsaturated; Glutamate Dehydrogenase; L-Lactate Dehydrogenase; Liver; Male; Rats; Rats, Inbred Strains; Reye Syndrome

1989